IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice
出版年份 2014 全文链接
标题
IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice
作者
关键词
-
出版物
Mucosal Immunology
Volume 7, Issue 5, Pages 1079-1093
出版商
Springer Nature
发表日期
2014-01-15
DOI
10.1038/mi.2013.124
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
- (2013) Azucena Salas GUT
- Interleukin-33 exacerbates acute colitis via interleukin-4 in mice
- (2013) Peter N. Pushparaj et al. IMMUNOLOGY
- The Role of IL-33 in Gut Mucosal Inflammation
- (2013) Luca Pastorelli et al. MEDIATORS OF INFLAMMATION
- Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation
- (2013) Z Su et al. Mucosal Immunology
- Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
- (2013) Anna Latiano et al. PLoS One
- Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
- (2012) Mamdouh A K Sedhom et al. GUT
- IL-33/ST2 axis in inflammation and immunopathology
- (2012) Marija Milovanovic et al. IMMUNOLOGIC RESEARCH
- ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
- (2012) John J. Arcaroli et al. Molecular Oncology
- Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents
- (2011) Renata FC Leitão et al. BMC GASTROENTEROLOGY
- Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor
- (2011) R Bertini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation
- (2011) Roberto César P. Lima-Júnior et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
- (2011) Ivan Jovanovic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A role for interleukin-33 in TH2-polarized intestinal inflammation?
- (2011) J B Seidelin et al. Mucosal Immunology
- Lactose maldigestion during methotrexate-induced gastrointestinal mucositis in a rat model
- (2010) M. Fijlstra et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs
- (2010) Richard M Logan et al. CANCER BIOLOGY & THERAPY
- Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model
- (2010) Di Xiang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
- (2010) Ayako Kobori et al. JOURNAL OF GASTROENTEROLOGY
- Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
- (2010) Jose C Alves-Filho et al. NATURE MEDICINE
- The Importance of Release of Proinflammatory Cytokines, ROS, and NO in Different Stages of Colon Carcinoma Growth and Metastasis After Treatment With Cytotoxic Drugs
- (2010) Roman Paduch et al. ONCOLOGY RESEARCH
- IL-33 is a crucial amplifier of innate rather than acquired immunity
- (2010) K. Oboki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
- (2010) Luca Pastorelli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
- (2010) B. McDonald et al. SCIENCE
- Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
- (2009) Alexander U. Lüthi et al. IMMUNITY
- IL-33 is upregulated in colonocytes of ulcerative colitis
- (2009) Jakob Benedict Seidelin et al. IMMUNOLOGY LETTERS
- Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
- (2009) Caroll J. Beltrán et al. INFLAMMATORY BOWEL DISEASES
- Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile
- (2009) Andrea M. Stringer et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Mucositis: from febrile neutropenia to febrile mucositis
- (2009) N. M. A. Blijlevens et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Current place of high-dose irinotecan chemotherapy in patients with metastatic colorectal cancer
- (2009) Mohamed Hebbar et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
- (2009) C. Cayrol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
- (2009) Alexander Stein et al. Therapeutic Advances in Medical Oncology
- Irinotecan-induced mucositis is associated with changes in intestinal mucins
- (2008) Andrea M. Stringer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?
- (2008) Richard M. Logan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?
- (2008) Christine Moussion et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started